EUVIMEDEUVIMED entdecken
Crossref

Distinctions in PCOS Induced by Letrozole Vs Dehydroepiandrosterone With High-fat Diet in Mouse Model

Pooja Suresh Poojary, Guruprasad Nayak, Gangotri Panchanan, Arpitha Rao, Sanjna Das Kundapur, Sneha Guruprasad Kalthur, Srinivas Mutalik iD, Satish Kumar Adiga, Yulian Zhao, Jamie Bakkum-Gamez, Alice Y Chang, Christopher DeStephano und 3 weitere

Endocrinology · 01.09.2022 · 163 (9)

DOI: 10.1210/endocr/bqac097 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrinology, online erschienen am 01.07.2022. Verfasst von Pooja Suresh Poojary und 14 weiteren Autor:innen. Beteiligte Einrichtung: Division of Clinical Embryology, Department of Reproductive Science, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal-…. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 88 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Polycystic ovarian syndrome (PCOS) is a complex health condition associated with metabolic disturbances and infertility. Recent data suggest that the prevalence of PCOS is increasing among women globally, although the etiology of these trends is undefined. Consequently, preclinical models that better reflect the biology of PCOS are urgently needed to facilitate research that can lead to the discovery of prevention strategies or improved management. The existing animal models have several limitations as they do not reflect all the PCOS features metabolically and/or phenotypically. Therefore, there is no clear consensus on the use of appropriate animal model and selection of the most appropriate PCOS-inducing agent. To that end, we have established a Swiss albino mouse model of PCOS based on 3 weeks of daily treatment with letrozole (50 μg/day; intraperitoneal) and dehydroepiandrosterone (DHEA, 6 mg/100 g body weight; subcutaneous) in 5-week-old female mice fed on normal or high-fat diet (HFD). Mice were regularly assessed for body weight, blood glucose, and estrous cycle. Three weeks after drug administration, mice were sacrificed and assessed for blood-based metabolic parameters as well as ovarian function. Our results indicate that DHEA combined with HFD produces changes mimicking those of clinical PCOS, including elevated serum testosterone and luteinizing hormone, dyslipidemia, poor ovarian microenvironment, and development of multiple ovarian cysts, recapitulating cardinal features of PCOS. In comparison, normal diet and/or letrozole produced fewer features of PCOS. The data from the experimental models presented here can improve our understanding of PCOS, a growing concern in women’s health.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polycystic Ovary SyndromeAnimalsBody WeightDehydroepiandrosteroneDiet, High-FatDisease Models, AnimalFemaleHumansLetrozoleMiceTumor Microenvironment

Stichwörter der Autor:innen

PCOSdyslipidemiaestrogen dominancehyperandrogenismovarian reservetestosterone

Substanzen

DehydroepiandrosteroneLetrozole

Autor:innen und Institutionen

  • Division of Clinical Embryology, Department of Reproductive Science, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal-576104, Karnataka, India.
  • Division of Reproductive Biology, Department of Reproductive Science, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal-576104, Karnataka, India.
  • Department of Anatomy, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal-576104, Karnataka, India.
  • Department of Pharmaceutics, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal-576104, Karnataka, India.
  • Department of Obstetrics and Gynecology and Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55902, USA.
  • Division of Laboratory Genetics and Genomics, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55902, USA.

ORCID-Profile: Srinivas Mutalik, Nagarajan Kannan, Guruprasad Kalthur

Zitieren

APA

Poojary, P. S., Nayak, G., Panchanan, G., Rao, A., Kundapur, S. D., Kalthur, S. G., Mutalik, S., Adiga, S. K., Zhao, Y., Bakkum-Gamez, J., Chang, A. Y., DeStephano, C., Sherman, M., Kannan, N., & Kalthur, G. (2022). Distinctions in PCOS Induced by Letrozole Vs Dehydroepiandrosterone With High-fat Diet in Mouse Model. Endocrinology, 163(9). https://doi.org/10.1210/endocr/bqac097

Vancouver

Poojary PS, Nayak G, Panchanan G, Rao A, Kundapur SD, Kalthur SG, et al. Distinctions in PCOS Induced by Letrozole Vs Dehydroepiandrosterone With High-fat Diet in Mouse Model. Endocrinology. 2022;163(9). doi:10.1210/endocr/bqac097

BibTeX
@article{Poojary2022,
  author = {Poojary, Pooja Suresh and Nayak, Guruprasad and Panchanan, Gangotri and Rao, Arpitha and Kundapur, Sanjna Das and Kalthur, Sneha Guruprasad and Mutalik, Srinivas and Adiga, Satish Kumar and Zhao, Yulian and Bakkum-Gamez, Jamie and Chang, Alice Y and DeStephano, Christopher and Sherman, Mark and Kannan, Nagarajan and Kalthur, Guruprasad},
  title = {Distinctions in PCOS Induced by Letrozole Vs Dehydroepiandrosterone With High-fat Diet in Mouse Model},
  journal = {Endocrinology},
  year = {2022},
  volume = {163},
  number = {9},
  doi = {10.1210/endocr/bqac097}
}
Kostenlos starten →